CORONA Remedies Pvt. Ltd. Our journey started in 2004, with a commitment to creating a better quality of health for all by being at the forefront of research, manufacturing and marketing of high quality products.

The candidate must possess a thorough understanding of relevant disease biology, the clinical landscape, emerging technologies, and the competitive environment. The candidate should demonstrate exceptional laboratory technical skills in cell and molecular biology, and, or in vivo pharmacology and proficient at devising strategic solutions to identify and resolve potential challenges.

Audit Response writing skill, Audit handling skill. Current Guideline assessment and compliance. Gap Assessment to overall Regulatory Compliance. Proficient in risk assessment, cleaning procedure optimization. Adept at collaborating with cross-functional teams to maintain robust cleaning validation programs.

Setting strategy for evaluating and implementing new technologies within the Analytical Development department, with a particular emphasis on state-of-the-art separation techniques

Skilled in handling equipment such as reactors, centrifuges CF, vacuum tray dryers VTD, agitated nutsche filters , etc. Strong expertise in unit operations. Well-versed in production activities including raw material verification, batch charging, batch monitoring, and GMP documentation.

Provide medical and scientific training to internal stakeholders, including the sales and marketing teams, ensuring accuracy and alignment with scientific evidence. Collaborate with cross-functional teams to support the development of strategic initiatives in line with medical and commercial objectives.

M.S. Pharm, M.Pharm, M.Tech or Equivalent with specialization in Pharmaceutics, Pharmacology and Toxicology, Biotechnology or Life Sciences from the recognized Board, University, Institute.

D.Pharm Council Registration Certificate will be required under the National Urban Health Mission

Candidate having experience in network pharmacology, cell culture protocols, molecular biology protocols, animal handling, surgery in experimental animals, will be given preference. Experience or basic knowledge in in vitro cell culture and fundamental knowledge of molecular pharmacology will be preferred.

PhD with 3 years experience in Biological Science, Biotechnology, Biochemistry, Bioengineering, Pharmaceutical Technology or any branch of Life Sciences Relevant to essential criteria. 

Post Graduate degree in Biotechnology Life Science subject with two year experience from recognized university. Post Graduate degree in Bio informatics subjects with two year experience from recognized university.

Hands-on experience in a professional pharmaceutical environment. Exposure to innovative practices, research methodologies, and industry standards. Opportunity to collaborate with skilled professionals and enhance your career prospects.

Have good exposure in Plant Maintenance & Instrumentation related work in sterile facility. Have good exposure in Sterile IPQA & Sterile Qualification Related activity.

Must be from Parenteral background & exposure to Aseptic vial, Bottle filling process is desirable. To be aware and responsible for achieving quality objective and fulfilling the requirements of applicable quality procedures. Sound technical knowledge of Aseptic area & Controlled area related activities.

As per the batch manufacturing procedures and packing protocols, samples such as in-process samples, finished product samples, stability samples, control samples, cleaning samples, and other samples should be collected and submitted

Having Injectable Experience of Analysis of raw material. In-process, Finish products, Stability testing, Process validation. Hands on Experience of HPLC, GC, LBPC, Osmometer, KF Auto titrator and UV - Visible spectrometer, LIMS,QMS,Participate in Lab incident , OOS, OOT, Analysis of deviation.

Collecting and reviewing adverse event reports to ensure accurate and timely reporting in accordance with regulatory guidelines. Conducting signal detection and risk assessment activities to identify potential safety issues.

Conduct preliminary review of laboratory results relative to established protocol-specific reference range guidelines, using relevant clinical laboratory experience and compares current results with prior laboratory values to evaluate or note clinically significant increases, decreases and contacts the investigator site for pertinent additional clinical contact for distribution to project team

Novo Nordisk is now discontinuing its Human Mixtard penfill by the year's end. However Mixtard in India will continue to be available in vials. Along with it, other forms of insulin including human insulin from Novo Nordisk will continue to be available in vials & devices for patients across India.